-+ 0.00%
-+ 0.00%
-+ 0.00%

Autolus Therapeutics Sees FY2026 Sales $120.000M-$135.000M vs $130.062M Est

Benzinga·05/14/2026 12:58:25
Listen to the news
Autolus Therapeutics (NASDAQ:AUTL) sees FY2026 sales of $120.000 million-$135.000 million vs $130.062 million analyst estimate.